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Physicochemical characteristics of glomerular basement
membrane antigens in urine
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Department ofimmunology. Institute of Child Health, University of London, London, England, and Department of
Pediatrics. University of Oulu, Oulu, Finland
Biochemical analysis of glomerular basement
membrane (GBM), first isolated by Krakower and
Greenspoon [1], has shown that it is composed of
collagen linked to glycoprotein [2]. in 1968, Haw-
kins and Cochrane reported that nephritic rabbits
excreted into their urine material antigenically re-
lated to GBM [3]. Lerner and Dixon similarly found
small amounts of it in the urine of normal rabbits
[4], and McPhaul and Dixon detected it in normal
human urine and showed it to be glycoprotein [5].
Urinary excretion of this GBM-related material,
now generally called GBM antigens, is increased in
various experimental [6-9] and human glomerular
diseases [10—14]. Furthermore, physicochemically
different GBM antigens have been observed in the
urine of nephritic rabbits [3, 8, 9] and in pathologic
human urine [14, 15].
We have used gel filtration and ion-exchange
chromatographic procedures to fractionate and to
characterize the GBM antigens present in normal
and pathologic human urine. We were especially in-
terested in studying the urinary GBM antigens of
children with congenital nephrotic syndrome of Fin-
nish type (CNF), because it has been suggested that
synthesis of GBM is abnormal in this disease [16].
Methods
Patients. Twenty-four-hour urine samples were
obtained from 7 children with renal disease; their
clinical data are presented in Table 1. Pools of urine
samples from 29 children with CNF, from 5 healthy
children, and from laboratory staff without overt
renal disease were also studied.
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Preparation of urine samples. Urine samples
containing merthiolate (1: 10,000) were filtered
(Whatman I 13V) and concentrated by vacuum dial-
ysis with 8/32 Visking tubing (Scientific Instrument
Centre Ltd., London). The 24-hour urine samples
with a high protein content were concentrated 10 to
120 times, whereas normal urine samples were con-
centrated about 1,000 times. After concentration
and dialysis (see below), the samples were centri-
fuged for 10 mm at X2000g, filtered through 0.22-
sm Millipore filter, and stored at —20° C until anal-
ysis.
To obtain an enriched solution of GBM antigens,
we fractionated the pooled CNF urine samples with
ammonium sulphate. Solid ammonium sulphate was
added gradually to concentrated urine with continu-
ous stirring until 40% saturation was achieved. The
precipitate was washed twice with 40% saturated
ammonium sulphate solution, redissolved in 0.01 M
phosphate buffered saline (PBS; pH, 7.3). No loss
of GBM antigens during this procedure was detect-
ed by gel diffusion analysis.
Determination of protein concentration. The to-
tal protein content in the urinary samples of patients
with heavy proteinuria was measured by the Biuret
method. Albumin concentrations were determined
by single radial immunodiffusion [17].
Anti-GBM serum. The isolation of human GBM
and the preparation of anti-GBM sera have been de-
scribed previously [12]. Briefly, GBM was sepa-
rated by a modification of the method of Krakower
and Greenspoon [1], sieving the renal cortex
through metal screens, sonicating the sieved gb-
meruli, and separating GBM from cellular debris by
centrifugation. The antiserum against human GBM
was raised in rabbits and absorbed with glutaralde-
hyde-polymerized human plasma proteins [18, 19].
The immunoglobulin was concentrated about three
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Table 1. Clinical details of the patients studied
Patient
no. Age Sex Diagnosisa
PCr
pinoles/liter
BUN
mrnoles/liter
Urine protein
mg/hr/rn2
I 2wk F CNF 92 — 113
2 4mo F DMS — 13 610
3 3yr M FGS 41 — 93
4 3yr F SSNS 28 — 123
5 6yr M SSNS,onsteroids 36 — 58
6 6yr M FGS 66 — 474
7 8yr F AS 109 — 169
a Abbreviations are CNF, congenital nephrotic syndrome of Finnish type; DMS, diffuse mesangial sclerosis; FGS, focal glomerular
sclerosis; SSNS, steroid-sensitive nephrotic syndrome; AS, Alport's syndrome.
times by precipitation with 50% saturated ammo-
nium sulphate. An aliquot of anti-GBM serum was
decomplemented by heating at 56° C, and absorbed
with the buffy coat of a donor of a red cell type AB
Rh-positive [20]. After absorption, no significant re-
duction in the titer of antibodies against GBM anti-
gen was observed.
Detection of GBM antigens. GBM antigens were
detected by double immunodiffusion against anti-
GBM-serum using plates of 1.5% agar (Difco, De-
troit, Michigan) in PBS (pH, 7.3). They were desig-
nated 1, 2, 3, and 4, as previously described [12].
The antigens in each sample investigated were iden-
tified by reactions of identity with a reference prep-
aration of known antigen at high concentration. In
selected samples, semiquantitative analysis was
done by doubling dilution.
Immunoelectrophoresis. Immunoelectrophoresis
was done in 1.5% agarose gel (Agarose B, Pharma-
cia Fine Chemicals, Uppsala, Sweden), in barbital
buffer (pH, 8.6; I = 0.045). Reference preparations
of whole human serum were included and devel-
oped with horse antihuman plasma protein serum
(Weilcome, Beckenham, England).
Gelfiltration. Serum and concentrated urine sam-
ples were dialyzed overnight against 0.1 M Tris-hy-
drochioric acid-0.2 M sodium chloride buffer (pH,
7.6) containing 0.02% sodium nitride, and fraction-
ated on Sephadex G 200 (5 x 87 to 91 cm) with the
same buffer. Sample volumes ranged from 6 to 25
ml. The columns were operated by upward flow at
54 to 61 mllhr, and the effluent was monitored con-
tinuously by a Uvicord II (LKB Producter, Upp-
sala, Sweden) at 280 nm. Fifteen-minute fractions
were collected, and the optical density (280 nm) of
alternate fractions was determined with an Optica
CF4 spectrophotometer. Starting with the first pro-
tein peak, we made pools of eight consecutive frac-
tions, and we concentrated them about 200 times
for the detection of GBM antigens. The range of
participation coefficient values (Kay) of each antigen
was calculated according to Laurent and Killander
[21], and the approximate molecular weights were
estimated by the method of Andrews, with the albu-
min and IgG of the samples as internal standards
[22].
Ion-exchange chromatography. Concentrated
normal urine and ammonium sulphate precipitated
CNF urine samples were dialyzed overnight against
0.01 M phosphate buffer (pH, 7.4) and fractionated
on a column of Whatman DE-52 cellulose (3.2 x 39
cm) equilibrated with the same buffer and eluted
with a gradient of increasing ionic strength from
0.01 to 0.2 M with a flow rate of 45 to 55 mllhr. The
volume of the applied samples was 30 ml (albumin
content, 2.8 glliter in normal urine and 1.1 g/liter in
CNF urine). Fifteen-minute fractions were collect-
ed, and the optical density (280 nm) of the effluent
was determined. The conductivities of alternate
fractions were measured with a Philips PR 9500
conductivity meter, and corresponding molar con-
centrations of phosphate were read from a standard
curve. Pools of eight individual fractions were made
and concentrated 200-fold by vacuum dialysis prior
to analysis.
Results
Three GBM antigens, Ag!, Ag2, and Ag3, were
detected in concentrated pooled normal urine by
immunodiffusion analysis. Of the three, Agl pro-
duced the most intense precipitation. After per-
forming gel filtration of this concentrate, we identi-
fied a fourth antigen (Ag4), antigenically dissimilar
to the other three, in the concentrated void volume
material. Three antigens (Ag!, Ag2, and Ag3) were
also detected in concentrated pooled CNF urine;
but in contrast to normal urine, Ag3 gave the
strongest precipitation. In the urine concentrates of
individual patients, only one antigen, either Ag 1 or
Ag3, was detected, except for patient 2 (see Table
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Fig. 1. Sephadex G 200 gelfiltration of concentrated pooled nor-
mal urine (A) and an ammonium sulphate-precipitated prepara-
tion of pooled urine from patients with congenital nephrotic syn-
drome of Finnish type (CNF) (B).
2) with diffuse mesangial sclerosis (DMS), in whose
urine both antigens were detected. The identifica-
tion of antigens in the fractions with relatively high
antigen concentration was unambiguous but occa-
sionally in some samples with low antigen concen-
tration the demonstration of identity with a refer-
ence antigen was difficult, especially in the case of
Ag3 in column fractions of normal urine.
Representative gel filtration profiles of normal,
CNF, steroid-sensitive nephrotic syndrome
(SSNS), and DMS urine concentrates and the semi-
quantitative estimates of GBM antigens in the
pooled fractions of these separations are shown in
Figs. 1 and 2.
Kay values and estimated molecular weights of
the GBM antigens are given in Table 2. Agi, espe-
Fig. 2. Sephadex G 200 gel filtration of concentrated urine sam-
ples from patients with steroid-sensitive nephrotic syndrome
(SSNS) (A) and diffuse mesangial sclerosis (DMS) (B).
cially in normal and pooled CNF urine, showed a
wide range of molecular size, and in all samples Agl
eluted with material having a molecular size of
60,000 to 200,000 daltons. In contrast, Ag3 of patho-
logic urine samples eluted over a smaller size range
and had an average molecular weight less than that
of albumin, but in normal urine it ranged from
90,000 to 180,000 daltons.
No GBM antigens were detected in uncon-
centrated normal serum or in the unfractionated
serum of a bilaterally nephrectomized patient. After
gel filtration of the latter, however, serum weakly
precipitating Ag3 was detected in the third protein
peak (Kay, 0.39 to 0.47; mol wt, 57,000 to 81,000
daltons).
Results from ion-exchange chromatography on
the pooled normal and CNF urine samples are pre-
sented in Fig. 3. Agi was eluted with albumin at
phosphate concentrations of 0.07 to 0.1 moles/liter,
but some was eluted also at a phosphate concentra-
tion of 0.15 moles/liter. The Ag2 and a third antigen,
Normal A
Ag2 [1
Ag3 ______
Ag4
500
—
1000 1500
Elution volume, ml
CNF B
Ag1
Ag 2
Ag 3
500 1000
Elation volume. ml
SSNS
_ _
I
500 1000 1500
Elution volume, ml
DMS
500 1000
-
1500
Elution volume, m/
Ag 1
L
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Table 2. Average participation coefficient (Kay) values and approximate molecular weights of urinary GBM antigens
(Ag!, Ag2, Ag3, and Ag4)
Patient
Ag! Ag2 Ag3 Ag4
Mol wt Mol wt Mo! wt Mol wt
no. Diagnosisa Kay X l0 daltons Kay X 10 daltons Kay )< l0 daltons Kay x 10 daltons
1 CNF 0.37to0.53 56to90
2 DMS 0.O6toO.25 !50to340 0.52to0.79 20to47
3 FGS 0.17to0.34 lOOto2lO
4 SSNS 0.05 to 0.58 35 to 350
5 SSNS 0.26 to 0.54 45 to 150
6 FGS 0.19 to 0.40 78 to 240
7 AS 0.39 to 0.47 28to 140
Pooled normal urine 0.03 to 0.64 25 to 380 0.21 to 0.64 25 to 180 0.21 to 0.37 90 to 180 <0.03 >380
PooledCNFurine O.O2toO.61 32to400 0.11 toO.28 !30to270 O.45to0.75 20to63
a Abbreviations are defined in Table 1.
presumably Ag3, of normal urine were eluted from
the column with the Agi peak. In contrast Ag3 and
most of the Ag2 in the CNF urine were eluted with
buffer of low molar concentration (see Fig. 3).
Two concentrated pools from the ion-exchange
fractions of normal and CNF urine were analyzed
by immunoelectrophoresis. Ag! of both samples
migrated anodically in the postalbumin area, where-
as Ag3, detected only in CNF urine, migrated cath-
odically (Fig. 4).
Discussion
It has been shown clearly in several studies that
urinary excretion of GBM antigens is increased in
many types of glomerular disease [3, 6-14]. Opin-
ions, however, differ on the number and phys-
icochemical properties of these antigens. Usually,
two or three distinct antigens have been detected in
normal rabbit urine [4, 8, 9]. Hawkins and Cochrane
observed that glomerular injury, induced in rabbits
by injection of sheep antirabbit GBM-serum, was
characterized by the excretion of antigens with a
higher molecular weight than that of the GBM anti-
gens in normal rabbit urine [3]. In similar circum-
stances, Boesken et a! and Batsford and Hardwicke
found a fourth GBM antigen as well, but some of
these antigens were clearly smaller than those of
normal rabbit urine [8, 9]. McPhaul and Dixon
found, however, only two antigens in normal hu-
man urine [5].
By a combination of gel filtration and immuno-
diffusion, we have detected four distinct antigens in
the urine of healthy people. Ag4 of the present
study might be related to the antigen of McPhaul
and Dixon which also eluted in the void volume of
Elutiori volume, ml
Fig. 3. Ion-exchange chromatography on DE-52 cellulose of
pooled normal urine (A) and an ammonium sulphate-precipitated
preparation of pooled urine from patients with congenital neph-
rotic syndrome of Finnish type (CNF) (B). The fractions labeled
I and 2 were used in the immunoelectrophoretic analyses shown
in Fig. 4.
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Fig. 4. A Immunoelectrophoretic analysis of selected fractions (identified as 1 and 2 in Fig. 3 upper profile) from the ion-exchange
chromatography of concentrated pooled normal urine. B Similar analysis of selected fractions from the ion-exchange chromatography
of ainmoniuni sulphate-precipitated pooled urine from patients with congenital nephrotic syndrome of Finnish type (identified as I and 2
in Fig. 3 lower profile). In both A and B, the uppermost well contained unfractionated pooled normal urine concentrate (WUC), and the
lower well contained normal human serum (NHS). Anti-GBM serum was added to the middle troughs and polyvalent anti-NHS serum to
the upper and lower troughs of each plate. The precipitation arc produced by the albumin in fraction 2 of normal urine is not seen because
it is in antigen excess. Anode is to the right.
Sephadex G 200. Ag! of the present study possibly
corresponds to the antigen of lower molecular
weight in McPhaul and Dixon's study. The number
of urinary GBM antigens detected, however, is in-
fluenced by the degree of concentration of the urine
samples studied. This may explain why four anti-
gens were detected in normal urine but not in the
less concentrated pathologic urine samples in our
study or in the normal urine studied by McPhaul
and Dixon [3]. Alternatively, qualitative differences
in the antisera raised against human GBM in dif-
ferent species may account for the observed dif-
ferences between our study and that of McPhaul
and Dixon. In addition, GBM shares antigenic de-
terminants with other basement membranes of the
body [23, 24], and thus an anti-GBM serum ob-
tained by immunization with crude GBM cannot
distinguish between antigens originating from GBM
and those released by other basement membranes
in the body.
Antigen 3, a minor component of normal urine,
was the predominant GBM antigen of patients with
CNF, DMS, and Alport's syndrome. The excretion
of this antigen, however, is not specific to these dis-
orders, because it was also detected in small
amounts in normal urine, but the average molecular
weight of Ag3 in pathologic urine was about 40,000
daltons, compared to 90,000 to 180,000 daltons in
normal urine, suggesting a qualitative difference.
Agi and Ag2 in the pathologic urine samples were
about the same size as that found in normal urine.
The ion-exchange chromatography and immuno-
electrophoretic analyses suggest that Ag2 and Ag3
of CNF urine are more positively charged than
these antigens in normal urine, but Agl was similar
in both cases.
GBM antigens have been detected in the serum of
both healthy individuals and anephric patients [3].
Huttunen et al showed previously that the antigen
in the serum of nephrectomized CNF patients gave
a reaction of identity with Ag3 in the urine of other
CNF patients [12]. In this study, we confirmed the
presence of Ag3 in the serum of a nephrectomized
patient with another renal disorder. These results
suggest that Ag3 may also originate from other
basement membranes in the body, and be cleared
through diseased glomeruli. In this case, the in-
creased excretion of Ag3 of lower molecular weight
in CNF urine might result from decreased tubular
reabsorption of filtered Ag3. On the other hand, the
following observations argue against an exclusively
extrarenal origin for Ag3: (a) Ag3 could not be de-
tected in the urine of patients with SSNS or focal
glomerular sclerosis (FGS), (b) the urinary excretion
of Ag3 in CNF increased with falling GFR [25], and
(c) increased amounts of Ag3 are seen in the urine
of patients not associated with tubular atrophy
[12]. It seems most probable that urinary GBM anti-
rv5 •
1
NH S
B
wuc
2
wuc
2
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gens are mainly released from glomeruli although
Ag3 may be cleared to some extent from plasma in-
to urine.
We have previously reported that the excretion of
both Agi and Ag3 is increased in various types of
glomerulonephritis and CNF, but not in SSNS [12].
Our present results show that the molecular weight
of the antigen in the urine of patients with SSNS or
FGS is similar to that of normal urine but different
in the urine of patients with DMS, Alport's syn-
drome, and CNF. If urinary GBM antigens are
membrane fragments, the quantitative and qualita-
tive patterns in various diseases may reflect dif-
ferent mechanisms of GBM injury. Furthermore,
the unusual GBM antigens in the urine of CNF pa-
tients may indicate an inherited disturbance of syn-
thesis or degradation of GBM in this disorder.
Summary
Glomerular basement membrane (GBM) antigens
in pooled normal urine and the pooled urine of in-
fants with congenital nephrotic syndrome of Fin-
nish type (CNF) have been characterized by gel fil-
tration, ion-exchange chromatography, and immu-
nodiffusion or immunoelectrophoretic analysis. Gel
filtration studies were also done on urine samples
from 7 individual children with various renal dis-
eases. Using a single antiserum, we found four
GBM antigens (Ag 1, 2, 3, and 4) in normal urine.
Agi consistently produced the strongest precipi-
tation in immunodiffusion analyses and was shown
to be heterogeneous with respect to both molecular
size (average mol wt, 100,000 daltons) and charge. In
contrast, Ag3 gave the most intense precipitation in
immunodiffusion analyses of urine concentrates
from patients with CNF, diffuse mesangial scle-
rosis, and Alport's syndrome. Ag3 in these urine
concentrates had an average mol wt of 40,000 dal-
tons, somewhat smaller than that of Ag3 in normal
urine. Agi was the only antigen to be detected in
the urine of patients with steroid-sensitive nephrot-
ic syndrome or focal glomerular sclerosis. In ion-
exchange chromatography, Ag2 and Ag3 of CNF
urine eluted at lower ionic strength than did the same
antigens in normal urine, suggesting qualitative as
well as quantitative differences. The observed het-
erogeneity of GBM fragments in different diseases
may reflect different underlying mechanisms re-
sponsible for GBM damage.
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